Hoppa till innehållet

Redeye: Tessin - Muted risk appetite holding back sales

Redeye updates its estimates and valuation after reviewing Tessin's Q4 report, which showed weaker figures than expected. Despite the accelerated decline in sales during the quarter, we believe there is potential for a rapid rebound if institutional capital were to be secured.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Source:MFN
Tillbaka

Det verkar som att du använder en annonsblockerare

Om du är prenumerant behöver du logga in för att fortsätta. Vill du bli prenumerant kan du läsa Di Digitalt för 197 kr inkl. moms de första 3 månaderna.

spara
1180kr
Prenumerera